NATERA GALAXY Study Links ctDNA Status to Survival & Treatment Response ESMO 2024 Colorectal 4 Mins Read68 The GALAXY Study has provided compelling data that highlights the predictive value of circulating tumor DNA (ctDNA) status in colorectal…
SLIDES: FDA Approves Kisqali / Ribociclib for Early High-Risk Breast Cancer Breast 2 Mins Read41 The FDA has recently approved Kisqali (ribociclib) in combination with a non-steroidal aromatase inhibitor (NSAI) for the treatment of early-stage…
Genetic Testing Cancer, Practice Changing? – Dr. Erica Giblin, MD Breast 3 Mins Read44 Genetic Testing Cancer In recent years, the field of oncology has witnessed significant advancements, particularly in the realm of genetic…
